At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 21 enrolled
Drug / intervention
Vitamin Ddietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vitamin D and Crohn's Disease" From the Bench to the Clinic
In Brief
A Phase 1 clinical trial evaluating Vitamin D for Inflammatory Bowel Disease. Completed, enrolled 21 participants across 2 sites.
Detailed Summary
The purpose of this study is to determine the effect of vitamin D supplementation in Crohn's disease patients. Patients will be evaluated for increases in circulating vitamin D levels and effects on health benefits including improved bone markers, Crohn's disease activity scores, and inflammatory markers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Bowel Disease
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 2008
Enrollment StartMay 2009
Primary CompletionAug 2011
Study CompletionDec 2011
TodayJul 2026
First PostedAug 28, 2008
Enrollment StartMay 1, 2009
Primary CompletionAug 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.8 years ago
Interventions
Vitamin Ddietary
Oral supplementation daily with up to 5000 IU over 6 months.